Improved imaging and the clinician: The the role of positron emission tomography in the management of colorectal cancer

被引:5
作者
Hecht, JR [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA
关键词
colon; colorectal; PET; staging; diagnosis;
D O I
10.1016/j.mibio.2004.04.005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Colorectal cancer is the second most common cause of cancer death in the United States and Western Europe. Positron emission tomography (PET) has been shown to be a valuable tool for the evaluation of malignancies of the breast, lung, and gastrointestinal tract. Potential areas of utility in patients with colorectal cancer include early detection, improved staging at the time of initial diagnosis, the detection and staging of recurrent disease, and early determination of treatment response. Despite continued advancement in the technical aspects of PET, the true measure of its worth is how well it assists the clinician in the care of the patient. To best use the information provided by PET, the nuclear medicine physician and oncologist must both understand the treatment choices available for patients at various stages in the disease. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:208 / 213
页数:6
相关论文
共 64 条
[31]   Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU) leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer [J].
Kabbinavar, F ;
Hurwitz, HI ;
Fehrenbacher, L ;
Meropol, NJ ;
Novotny, WF ;
Lieberman, G ;
Griffing, S ;
Bergsland, E .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :60-65
[32]  
Kalff V, 2002, J NUCL MED, V43, P492
[33]   Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. [J].
Kemeny, N ;
Huang, Y ;
Cohen, AM ;
Shi, WJ ;
Conti, JA ;
Brennan, MF ;
Bertino, JR ;
Turnbull, ADM ;
Sullivan, D ;
Stockman, J ;
Blumgart, LH ;
Fong, YM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (27) :2039-2048
[34]   Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer [J].
Kemeny, N ;
Jarnagin, W ;
Gonen, M ;
Stockman, J ;
Blumgart, L ;
Sperber, D ;
Hummer, A ;
Fong, Y .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) :3303-3309
[35]   Systematic review of the efficacy and safety of colorectal stents [J].
Khot, UP ;
Lang, AW ;
Murali, K ;
Parker, MC .
BRITISH JOURNAL OF SURGERY, 2002, 89 (09) :1096-1102
[36]  
Köckerling F, 1998, J CLIN ONCOL, V16, P324
[37]   Randomised study of screening for colorectal cancer with faecal-occult-blood test [J].
Kronborg, O ;
Fenger, C ;
Olsen, J ;
Jorgensen, OD ;
Sondergaard, O .
LANCET, 1996, 348 (9040) :1467-1471
[38]   EFFECTIVE SURGICAL ADJUVANT THERAPY FOR HIGH-RISK RECTAL-CARCINOMA [J].
KROOK, JE ;
MOERTEL, CG ;
GUNDERSON, LL ;
WIEAND, HS ;
COLLINS, RT ;
BEART, RW ;
KUBISTA, TP ;
POON, MA ;
MEYERS, WC ;
MAILLIARD, JA ;
TWITO, DI ;
MORTON, RF ;
VEEDER, MH ;
WITZIG, TE ;
CHA, S ;
VIDYARTHI, SC .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (11) :709-715
[39]   A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels [J].
Libutti, SK ;
Alexander, HR ;
Choyke, P ;
Bartlett, DL ;
Bacharach, SL ;
Whatley, M ;
Jousse, F ;
Eckelman, WC ;
Kranda, K ;
Neumann, RD ;
Carrasquillo, JA .
ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (10) :779-786
[40]   A PROSPECTIVE RANDOMIZED COMPARISON OF CONTINUOUS INFUSION FLUOROURACIL WITH A CONVENTIONAL BOLUS SCHEDULE IN METASTATIC COLORECTAL-CARCINOMA - A MID-ATLANTIC ONCOLOGY PROGRAM STUDY [J].
LOKICH, JJ ;
AHLGREN, JD ;
GULLO, JJ ;
PHILIPS, JA ;
FRYER, JG .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) :425-432